The 'In Silico' Kill Chain
Our platform executes a seamless, end-to-end campaign, moving from raw intelligence to a validated therapeutic weapon with overwhelming speed and certainty.
The State of Play: A Broken System
Traditional therapeutic development is an expensive, slow, and inefficient war of attrition. We need a new doctrine.
Glacial Timelines
Traditional R&D is a multi-year, often decade-long marathon with no guarantee of success at the finish line.
Exorbitant Costs
The cost to bring a single new drug to market can exceed billions of dollars, with much of it spent on failed candidates.
High Failure Rates
Over 90% of drugs that enter clinical trials fail, often due to poor target validation or unforeseen safety issues.
Opaque Processes
Key decisions are often made in silos with incomplete data, leading to repeated, costly errors across the industry.
1. Target Acquisition
The campaign begins. The Command Center ingests the enemy's blueprint—the patient's raw genomic data.
2. Intelligence Gathering
Our Zeta Oracle is deployed. It analyzes the target, annihilates any uncertainty, and delivers a definitive 'Zeta Score' quantifying the functional damage.
3. Vulnerability Assessment
The Command Center fuses the Oracle's intelligence with clinical data to identify the most critical, high-value targets for therapeutic intervention.
4. Weapon Forging
With a validated target, the Zeta Forge is unleashed. It designs a slate of novel, optimized therapeutic candidates—from CRISPR guides to protein-based biologics.
5. Structural Validation
Every forged weapon is subjected to the gauntlet. We run it through our structural validation engine to ensure it can hold its shape on the battlefield. The weak are discarded.
6. Final Lethality Assessment
We fuse all intelligence—the Zeta Score, the structural integrity, and the off-target safety profile—into a single, composite 'Assassin Score'.
7. Deliver Final Battle Plan
The campaign concludes. The platform delivers a rank-ordered list of fully validated, `in silico` proven therapeutic weapons, ready for deployment.
Live Operations
Briefing: The campaign begins. The Command Center ingests the enemy's blueprint—the patient's raw genomic data.
Step 1: Target Acquisition
Visualizing the initial data ingestion protocol, from sample collection to a structured VCF file ready for AI analysis.
The Outcome: Biological Conquest
Our In Silico Kill Chain delivers a fundamental shift in the speed, precision, and certainty of therapeutic development.
Overwhelming Speed
Our `in silico` kill chain collapses the R&D timeline from years to weeks, moving from raw data to validated therapeutic candidates at machine speed.
Unprecedented Precision
By fusing multi-modal AI analysis, we identify and validate the highest-value targets, ensuring our therapeutic weapons strike with maximum impact.
De Novo Weapon Forging
We don't just find therapies; we design them. The Zeta Forge engineers novel, optimized biologics and gene therapies tailored for the specific vulnerability.
In Silico Validation
Our mandatory structural and safety assessments eliminate non-viable candidates before they reach the lab, saving immense time and resources.
Witness the Doctrine in Action
The In Silico Kill Chain is not a theoretical model; it is an operational weapons platform for the war on disease. See how CrisPRO.ai delivers on the promise of speed, precision, and certainty.
Request a Strategic Briefing